Abstract
Copy number variation (CNV) is an emerging approach to study about human health and diseases. Liver-related biochemical tests (aspartate aminotransferase: AST, alanine aminotransferase: ALT) are useful for diagnosing a patient with liver injury. We analyzed a CNV-based GWAS of AST and ALT in 407 Korean. Affymetrix Human 6.0 Array was used to identify CNV, and CNV segmentation was performed using CNV analysis software. Univariate linear regression was used for the GWAS using R package. We identified 64 CNVs associated with AST or ALT, and screened 228 genes located within our CNVs. In this study, we focused on semantic networks about liver disease using knowledge integration software. This semantic networks about liver disease contained entities like gene, disease, pathway, chemical, drug, and contained relationships between two entities like gene-pathway, gene-disease, pathway-chemical, disease-pathway, chemical-drug. Application of semantic networks shown three clusters, including four diseases (hepatocellular carcinoma, liver neoplasm, liver cell adenoma, drug-induced liver injury), one pathway (hepatitis C pathway), and seven drugs (acetaminophen, chlormezanone, stavudine, enflurane, isoniazid, mebendazole, nitisinone).
Article PDF
Similar content being viewed by others
References
Thapa, B. & Walia, A. Liver function tests and their interpretation. Indian J Pediatr 74:663–671 (2007).
Ruhl, C. E. & Everhart, J. E. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology 55:447–454 (2012).
Hsueh, C. J., Wang, J. H., Dai, L. & Liu, C. C. Development of an Electrochemical-Based Aspartate Aminotransferase Nanoparticle Ir-C Biosensor for Screening of Liver Diseases. Biosensors 2:234–244 (2012).
Lee, B. Y., Cho, S., Shin, D. H. & Kim, H. Genomewide association study of copy number variations associated with pulmonary function measures in Korea Associated Resource (KARE) cohorts. Genomics 97: 101–105 (2011).
McCarroll, S. A. & Altshuler, D. M. Copy-number variation and association studies of human disease. Nature Genetics 39:S37–S42 (2007).
Kim, H. Y., Yu, J. & Kim, H. Analysis of copy number variation in 8,842 Korean individuals reveals 39 genes associated with hepatic biomarkers AST and ALT. BMB reports 43:547–553 (2010).
Redon, R. et al. Global variation in copy number in the human genome. Nature 444:444–454 (2006).
Zhang, Y. et al. Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information. BMC Medical Genomics 3:1 (2010).
Houlston, R. S. et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nature Genetics 40:1426–1435 (2008).
Kim, H. Y. et al. Semantic data integration for toxicogenomic laboratory experiment management systems. Toxicology and Environmental Health Sciences 3:135–143 (2011).
Shin, G. H. et al. mRNA-centric semantic modeling for finding molecular signature of trace chemical in human blood. Mol Cell Toxicol 8:35–41 (2012).
Forbes, S. A. et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Research 39:D945–D950 (2011).
Kampstra, P. Beanplot: A boxplot alternative for visual comparison of distributions (2008).
Davis, A. P. et al. Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical gene disease networks. Nucleic Acids Research 37: D786–D792 (2009).
Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research 34:D668–D672 (2006).
Overbeek, R. et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Research 33:5691–5702 (2005).
Higgins, M. E., Claremont, M., Major, J. E., Sander, C. & Lash, A. E. CancerGenes: a gene selection resource for cancer genome projects. Nucleic Acids Research 35: D721–D726 (2007).
Taniguchi, K. et al. I. Mutational spectrum of betacatenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21:4863 (2002).
Liu, K., Hogan, W. R. & Crowley, R. S. Natural Language Processing methods and systems for biomedical ontology learning. Journal of Biomedical Informatics 44:163–179 (2011).
Zucman-Rossi, J. Benign Liver Tumors. Molecular Pathology of Liver Diseases 769–775 (2011).
Davern, T. J. Drug-induced liver disease. Clinics in Liver Disease 16:231 (2012).
Björnsson, E. S. & Chalasani, N. Drug-Induced Liver Injury. Practical Gastroenterology and Hepatology: Liver and Biliary Disease 235–242 (2010).
Farazi, P. A. & DePinho, R. A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature Reviews Cancer 6:674–687 (2006).
Warrell, D. & Anderson, S. eds. Expedition medicine. London: Profile Books, 1998.
Steinkühler, C. et al. Product inhibition of the hepatitis C virus NS3 protease. Biochemistry 37:8899–8905 (1998).
Lee, W. M. Drug-induced hepatotoxicity. New England Journal of Medicine 349:474–485 (2003).
Davidson, D. & Eastham, W. Acute liver necrosis following overdose of paracetamol. British Medical Journal 2:497–499 (1966).
Kullai Reddy Ulavapalli, J., Pyreddy, U. R. M. V. R. & Bobbarala, V. Indian Journal of Novel Drug Delivery. Indian Journal of Novel Drug delivery 3:134–142 (2011).
Miller, M. J., Krupp, I. M., Little, M. D. & Santos, C. Mebendazole. JAMA: The Journal of the American Medical Association 230:1412–1414 (1974).
Have, I. Previous version-Roundworm. Hospitals 121: 0357.
De Clercq, D. et al. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. American Journal of Tropical Medicine and Hygiene 57:25–30 (1997).
Yim, S. H. et al. Copy number variations in East-Asian population and their evolutionary and functional implications. Human Molecular Genetics 19:1001–1008 (2010).
Kim, H. Y., Byun, M. J. & Kim, H. A replication study of genome-wide CNV association for hepatic biomarkers identifies nine genes associated with liver function. BMB reports 44: 578–583 (2011).
Rasmussen, H. Cell communication, calcium ion, and cyclic adenosine monophosphate. Science 170:404–412 (1970).
Williamson, J. R., Cooper, R. H. & Hoek, J. B. Role of calcium in the hormonal regulation of liver metabolism. Biochim Biophys Acta 639:243 (1981).
山口 正義 & 山本 丈夫. Purification of calcium binding substance from soluble fraction of normal rat liver. Chem Pharm Bull 26:1915–1918 (1978).
Mori, S. & Yamaguchi, M. Hepatic calcium-binding protein regucalcin decreases Ca2+/calmodulin-dependent protein kinase activity in rat liver cytosol. Chem Pharm Bull 38:2216 (1990).
Leese, T., Farges, O. & Bismuth, H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Annals of Surgery 208:558 (1988).
Edmondson, H. A., Henderson, B. & Benton, B. Livercell adenomas associated with use of oral contraceptives. New England Journal of Medicine 294:470–472 (1976).
Beasley, R. P., Lin, C. C., Hwang, L. Y. & Chien, C. S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. The Lancet 318:1129–1133 (1981).
Bressac, B., Kew, M., Wands, J. & Ozturk, M. Selective G to T mutations of p 53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429–431 (1991).
Sommadossi, J. P. Comparison of Metabolism and in vitro antiviral activity of stavudine versus other 2′, 3′-Dideoxynucleoside Analogues. J Infect Dis 171:S88 (1995).
Santra, S. & Baumann, U. Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1 informahealthcare (2008).
Lambert, C. HelixTree® Genetics Analysis Software. Golden Helix. Inc. http//wwwgoldenhelixcom (2005).
Karolchik, D. et al. The UCSC genome browser database. Nucleic Acids Research 31:51–54 (2003).
Dennis, Jr, G. et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, HY., Park, JH., Kim, H. et al. Semantic networks for genome-wide CNV associated with AST and ALT in Korean cohorts. Mol. Cell. Toxicol. 9, 103–111 (2013). https://doi.org/10.1007/s13273-013-0014-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-013-0014-3